Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Discordant HER2/Neu Status Between Primary Tumor and Axillary Lymph Node in Breast Cancer Patients.

NCT01935739 is registered in ClinicalTrials.gov with National Cancer Institute, Thailand as lead sponsor.

NCT NCT01935739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01935739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Discordant HER2/Neu Status Between Primary Tumor and Axillary Lymph Node in Breast Cancer Patients.
Lead sponsor
National Cancer Institute, Thailand
Phase
Observational
Overall status
Completed
Start date
June 30, 2010
Completion date
June 30, 2011
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasm of breast.